Mergers & Acquisitions - Hi-Tech Pharmacal


Current filters:

Hi-Tech Pharmacal

Popular Filters

FTC imposes conditions on Akorn’s proposed buy of Hi-Tech Pharmacal


In order to consummate the proposed $640 million acquisition of Hi-Tech Pharmacal by fellow USA-based…

ActavisAkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth AmericaUSA

Akorn buy of Hi-Tech Pharmacal delayed by FTC request


In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Akorn buys rival generic drugmaker for $640 million


USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Back to top